<DOC>
	<DOCNO>NCT00057395</DOCNO>
	<brief_summary>To determine rate response duration response follow therapy Aroplatinin patient advance solid malignancy .</brief_summary>
	<brief_title>A Safety Effectiveness Study Aroplatin Patients With Advanced Solid Malignancies</brief_title>
	<detailed_description>Primary Objective : - Determine response rate ( RR ; complete partial response [ CR , PR ] ) duration therapy Aroplatinâ„¢ patient advance solid malignancy . Secondary Objective : - Determine safety tolerability Aroplatin</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>bis-neodecanoato-1,2-diaminocyclohexaneplatinum ( II )</mesh_term>
	<criteria>Advanced solid malignancy ; Amenable therapy DACH platinum agent ; Measurable disease ( RECIST criterion ) ; ECOG performance score 02 ; Adequate hematopoietic , liver renal function ; Adequate cardiac function ( maximum class II , NYHA ) ; Women childbearing potential must negative urine serum pregnancy test ; Signed write informed consent ; Subjects must willing follow course treatment/observation followup . No active malignancy ; No prior therapy oxaliplatin ; No know brain metastasis ; Active , uncontrolled infection serious medical illness ; Not use use investigational therapy four week start protocol treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2004</verification_date>
	<keyword>Esophageal Neoplasms</keyword>
	<keyword>Esophagus Neoplasm</keyword>
	<keyword>Esophagus Cancer</keyword>
	<keyword>Esophageal Cancer</keyword>
	<keyword>Esophageal Tumors</keyword>
	<keyword>Esophagus Tumors</keyword>
	<keyword>Neoplasms , Esophageal</keyword>
	<keyword>Hepatocellular Carcinoma</keyword>
	<keyword>Carcinoma , Hepatocellular</keyword>
	<keyword>Hepatoma</keyword>
	<keyword>Colorectal Neoplasms</keyword>
	<keyword>Colorectal Cancer</keyword>
	<keyword>Colorectal Carcinoma</keyword>
	<keyword>Colorectal Tumor</keyword>
	<keyword>Neoplasms , Colorectal</keyword>
	<keyword>Ovarian Neoplasms</keyword>
	<keyword>Ovary Neoplasms</keyword>
	<keyword>Ovary Cancer</keyword>
	<keyword>Ovary Carcinoma</keyword>
	<keyword>Ovarian Cancer</keyword>
	<keyword>Ovarian Carcinoma</keyword>
	<keyword>Neoplasms , Ovarian</keyword>
	<keyword>Pancreatic Neoplasms</keyword>
	<keyword>Pancreatic Cancer</keyword>
	<keyword>Pancreas Neoplasms</keyword>
	<keyword>Pancreas Cancer</keyword>
	<keyword>Neoplasms , Pancreatic</keyword>
	<keyword>Neoplasms , Pancreas</keyword>
	<keyword>solid tumor</keyword>
</DOC>